FloDesign Sonics is developing novel technologies to enable cell and gene therapy manufacturing at scale. The technologies comprise patented scalable, acousto-fluidics platforms to perform cell processes and manipulations, such as concentration, washing, differentiation, sorting, and culturing.
Our product pipeline includes equipment and disposable sets capable of performing multiple unit processes. Initial product offerings will deliver closed and scalable concentrate/wash, cell retention (during perfusion culture) and affinity cell selection functionality and the future pipeline includes viral transduction, label-free selection and new technologies to support virus manufacturing. FDS’s acoustic technologies are a closed, low shear, scalable solution to most cell and gene therapy manufacturing challenges.
Chris Leidel and our CEO Stanley Kowalski will be at JP Morgan so maybe they could meet you there and I could dial in from Australia? Afternoon times will be best for me and I’m connecting you to Chris above to assist in managing the calendars to set up the meeting.